COV — CLEO Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$42.50m
- AU$36.28m
- AU$1.95m
Annual cashflow statement for CLEO Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | — | — | 0.56 | 1.15 | 1.96 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0 | -0.684 | -2.03 | -2.9 | -4.94 |
| Capital Expenditures | -0.2 | -0.34 | -0.003 | -0.011 | -0.009 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.2 | -0.34 | -0.003 | -0.011 | -0.009 |
| Financing Cash Flow Items | 0.2 | -0.182 | -0.834 | 0 | -0.29 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.243 | 1.22 | 11.2 | 0 | 4.71 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.043 | 0.197 | 9.13 | -2.91 | -0.237 |